Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Liabilities and Shareholders Equity (2020 - 2024)

Intelligent Bio Solutions has reported Liabilities and Shareholders Equity over the past 5 years, most recently at $17.0 million for Q1 2024.

  • Quarterly results put Liabilities and Shareholders Equity at $17.0 million for Q1 2024, up 59.71% from a year ago — trailing twelve months through Mar 2024 was $44.9 million (down 12.31% YoY), and the annual figure for FY2023 was $10.4 million, down 16.17%.
  • Liabilities and Shareholders Equity for Q1 2024 was $17.0 million at Intelligent Bio Solutions, up from $8.8 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for INBS hit a ceiling of $21.9 million in Q2 2021 and a floor of $2.5 million in Q2 2020.
  • Median Liabilities and Shareholders Equity over the past 5 years was $14.4 million (2022), compared with a mean of $13.8 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 782.98% in 2021 and later plummeted 51.09% in 2023.
  • Intelligent Bio Solutions' Liabilities and Shareholders Equity stood at $20.0 million in 2020, then dropped by 23.69% to $15.2 million in 2021, then grew by 18.46% to $18.0 million in 2022, then plummeted by 51.09% to $8.8 million in 2023, then surged by 93.03% to $17.0 million in 2024.
  • The last three reported values for Liabilities and Shareholders Equity were $17.0 million (Q1 2024), $8.8 million (Q4 2023), and $8.7 million (Q3 2023) per Business Quant data.